Paying users zone. Data is covered by 
.
Get 1 month access to Pfizer Inc. for $19.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Pfizer Inc. (PFE)
Enterprise Value (EV)
Difficulty: Intermediate
Current Enterprise Value (EV)
Pfizer Inc., current enterprise value calculation
| Current share price (P) | $ |
| No. shares of common stock outstanding | |
| USD $ in millions | |
| Common equity (market value) | |
| Add: Preferred stock, no par value, at stated value (per books) | |
| Add: Equity attributable to noncontrolling interests (per books) | |
| Total equity | |
| Add: Short-term borrowings, including current portion of long-term debt (per books) | |
| Add: Long-term debt, excluding current portion (per books) | |
| Total equity and debt | |
| Less: Cash and cash equivalents | |
| Less: Short-term investments | |
| Enterprise value (EV) | |
Based on: 10-K (filing date: 2019-02-28).
Historical Enterprise Value (EV)
Pfizer Inc., EV calculation
Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).
1 Data adjusted for splits and stock dividends.
2 Close price on the filing date of Pfizer Inc.’s Annual Report.
| Item | Description | The company |
|---|---|---|
| EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Pfizer Inc.’s EV increased from 2016 to 2017 and from 2017 to 2018. |